Learn More
Summary:Allogeneic SCT for myeloma may be curative for young patients, but its role remains controversial because of a reported high TRM in some series. Since 1991, we have performed 25 allografts(More)
Summary:We treated 17 patients with refractory (n=7) or relapsed lymphoid malignancy (n=10) following allogeneic HSCT with donor lymphocyte infusions (DLI). Patients with low-grade disease received(More)